Literature DB >> 16682673

Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.

M S Beeri1, M Rapp, J M Silverman, J Schmeidler, H T Grossman, J T Fallon, D P Purohit, D P Perl, A Siddiqui, G Lesser, C Rosendorff, V Haroutunian.   

Abstract

OBJECTIVE: To examine the associations between postmortem Alzheimer disease (AD) neuropathology and autopsy-verified cardiovascular disease.
METHODS: The authors examined 99 subjects (mean age at death = 87.6; SD = 8.7) from the Mount Sinai School of Medicine Department of Psychiatry Brain Bank who were devoid of cerebrovascular disease-associated lesions or of non-AD-related neuropathology. Density of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) as well as coronary artery and aortic atherosclerosis, left ventricular wall thickness, and heart weight were measured. Partial correlations were used to assess the associations of the four cardiovascular variables with NPs and NFTs in the hippocampus, entorhinal cortex, and multiple regions of the cerebral cortex after controlling for age at death, sex, dementia severity, body mass index, and ApoE genotype. These analyses were also repeated separately for ApoE4 carriers and noncarriers.
RESULTS: The extent of coronary artery disease and to a lesser extent atherosclerosis were significantly associated with the density of cardinal neuropathologic lesions of AD in this autopsy sample (significant correlations between 0.22 and 0.29). These associations were more pronounced for the ApoE4 allele carriers (n = 42; significant correlations between 0.34 and 0.47).
CONCLUSIONS: The degree of coronary artery disease is independently associated with the cardinal neuropathological lesions of Alzheimer disease. These associations are primarily attributable to individuals with the ApoE4 allele.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682673      PMCID: PMC3163092          DOI: 10.1212/01.wnl.0000210447.19748.0b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

Review 1.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Observations on the brains of non-demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1968 Sep-Oct       Impact factor: 3.181

4.  Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease.

Authors:  D L Sparks; J C Hunsaker; S W Scheff; R J Kryscio; J L Henson; W R Markesbery
Journal:  Neurobiol Aging       Date:  1990 Nov-Dec       Impact factor: 4.673

5.  Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.

Authors:  Alex E Roher; Chera Esh; Tyler A Kokjohn; Walter Kalback; Dean C Luehrs; James D Seward; Lucia I Sue; Thomas G Beach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

Review 6.  Hypertension, hypertension-clustering factors and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2003-09       Impact factor: 2.448

Review 7.  Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms.

Authors:  Dorota Religa; Bengt Winblad
Journal:  Acta Neurobiol Exp (Wars)       Date:  2003       Impact factor: 1.579

8.  Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study.

Authors:  Pei-Ning Wang; Chueh-Lien Yang; Ker-Neng Lin; Wei-Ta Chen; Leh-Chii Chwang; Hsiu-Chih Liu
Journal:  J Neurol       Date:  2004-03       Impact factor: 4.849

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Cholesterol and APOE genotype interact to influence Alzheimer disease progression.

Authors:  R M Evans; S Hui; A Perkins; D K Lahiri; J Poirier; M R Farlow
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

View more
  41 in total

1.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

2.  Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.

Authors:  Ulrika K Eriksson; Anna M Bennet; Margaret Gatz; Paul W Dickman; Nancy L Pedersen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

3.  Hypertension is associated with cognitive decline in elderly people at high risk for dementia.

Authors:  Michael Wysocki; Xiaodong Luo; James Schmeidler; Karen Dahlman; Gerson T Lesser; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

Review 4.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

5.  Heart and brain tissue banks for research on co-occurring cardiovascular and neurological/psychiatric disorders.

Authors:  Milos D Ikonomovic
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-04-15

6.  Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease.

Authors:  Katherine J Bangen; Daniel A Nation; Lisa Delano-Wood; Gali H Weissberger; Lawrence A Hansen; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

7.  Genetic resilience to amyloid related cognitive decline.

Authors:  Timothy J Hohman; Logan Dumitrescu; Nancy J Cox; Angela L Jefferson
Journal:  Brain Imaging Behav       Date:  2017-04       Impact factor: 3.978

8.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

9.  Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.

Authors:  Akin Oni-Orisan; Lars V Kristiansen; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Biol Psychiatry       Date:  2007-12-26       Impact factor: 13.382

10.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.